TW1 <GO>TARGET WATCH2 <GO>MARKETLIVE
API

Genovis

SEFirst North
Latest price
20.30 SEK
17/09/2026
Latest (1)
28.00 SEK
+37.93%
Upside
GENO
3 mo+37.93%1 price targets
6 mo+47.78%3 price targets
1 yr+42.86%4 price targets
Max 4 price targets
Arctic
HealthcareBiotechnology

About The Company

Genovis was founded in 1999 by Sarah Fredriksson, who was CEO of Genovis until May 2015, when she became chairman of the board. The business was initially focused on nanoparticles intended for both the preclinical and clinical market.
Genovis

Latest Target

The most recently set price target for the stock, from a single analyst.

Target
28.00 SEK
Upside
+37.93%
Latest price20.30 SEK
Arctic
ArcticSep 7
28.00 SEK

Consensus

Consensus
29.00 SEK
Upside
+42.86%

Based on older targets - no fresh targets in the last 90 days.

Latest price20.30 SEK
Arctic
ArcticSep 7
28.00 SEK
Nordea
NordeaApr 29
30.00 SEK
SEB
SEBApr 10
32.00 SEK
Danske Bank
Danske BankFeb 13
28.00 SEK

Insider Trades for Genovis

No insider trades for the selected period.

More Price Targets for Genovis

Analyst
ArcticArctic
Hit rate 63 %
Date
Sep 7
Target
28.00 SEK
Analyst
NordeaNordea
Hit rate 51 %
Date
Apr 29
Target
30.00 SEK
Analyst
SEBSEB
Hit rate 62 %
Date
Apr 10
Target
32.00 SEK
Analyst
Danske BankDanske Bank
Hit rate 56 %
Date
Feb 13
Target
28.00 SEK